tinidazole has been researched along with Antibiotic-Associated Colitis in 4 studies
Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.
Excerpt | Relevance | Reference |
---|---|---|
"Since 2002, an epidemic of Clostridium difficile infections has occurred in southern Quebec, Canada." | 1.35 | Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. ( Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M, 2008) |
"Pouchitis is the most common long-term sequela of ileal pouch-anal anastomosis (IPAA) following total proctocolectomy." | 1.33 | Clostridium difficile-associated pouchitis. ( Bennett, AE; Fazio, VW; Goldblum, JR; Hull, TL; Remzi, FH; Shen, B, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hecht, DW | 1 |
Galang, MA | 1 |
Sambol, SP | 1 |
Osmolski, JR | 1 |
Johnson, S | 1 |
Gerding, DN | 1 |
Labbé, AC | 1 |
Poirier, L | 1 |
Maccannell, D | 1 |
Louie, T | 1 |
Savoie, M | 1 |
Béliveau, C | 1 |
Laverdière, M | 1 |
Pépin, J | 1 |
Shen, B | 1 |
Goldblum, JR | 1 |
Hull, TL | 1 |
Remzi, FH | 1 |
Bennett, AE | 1 |
Fazio, VW | 1 |
Jodlowski, TZ | 1 |
Oehler, R | 1 |
Kam, LW | 1 |
Melnychuk, I | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis[NCT00583076] | Phase 2 | 19 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for tinidazole and Antibiotic-Associated Colitis
Article | Year |
---|---|
Emerging therapies in the treatment of Clostridium difficile-associated disease.
Topics: Anti-Infective Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunoglob | 2006 |
3 other studies available for tinidazole and Antibiotic-Associated Colitis
Article | Year |
---|---|
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enter | 2007 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acqu | 2008 |
Clostridium difficile-associated pouchitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Hum | 2006 |